162 related articles for article (PubMed ID: 8201676)
41. The characterization of bacterial and nonbacterial prostatitis by prostatic immunoglobulins.
Shortliffe LM; Wehner N
Medicine (Baltimore); 1986 Nov; 65(6):399-414. PubMed ID: 3537628
[TBL] [Abstract][Full Text] [Related]
42. The common parasite Toxoplasma gondii induces prostatic inflammation and microglandular hyperplasia in a mouse model.
Colinot DL; Garbuz T; Bosland MC; Wang L; Rice SE; Sullivan WJ; Arrizabalaga G; Jerde TJ
Prostate; 2017 Jul; 77(10):1066-1075. PubMed ID: 28497488
[TBL] [Abstract][Full Text] [Related]
43. Acute and chronic bacterial prostatitis due to E. coli. Description of an animal model.
Jantos C; Altmannsberger M; Weidner W; Schiefer HG
Urol Res; 1990; 18(3):207-11. PubMed ID: 2204173
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic effect of melittin on a rat model of chronic prostatitis induced by Complete Freund's Adjuvant.
Lin L; Zhu BP; Cai L
Biomed Pharmacother; 2017 Jun; 90():921-927. PubMed ID: 28441718
[TBL] [Abstract][Full Text] [Related]
45. [Morphological and proinflammatory expression of the experimental autoimmune prostatitis in the rat model].
Chen L; Xia WP; Zhou ZH
Zhonghua Nan Ke Xue; 2007 May; 13(5):444-8. PubMed ID: 17569264
[TBL] [Abstract][Full Text] [Related]
46. Implications of prostate inflammation on male fertility.
Motrich RD; Salazar FC; Breser ML; Mackern-Oberti JP; Godoy GJ; Olivera C; Paira DA; Rivero VE
Andrologia; 2018 Dec; 50(11):e13093. PubMed ID: 30569650
[TBL] [Abstract][Full Text] [Related]
47. Unraveling CCL20's role by regulating Th17 cell chemotaxis in experimental autoimmune prostatitis.
Zhang C; Xu S; Hu RJ; Liu XH; Yue SY; Li XL; Dai BS; Liang CZ; Zhan CS
J Cell Mol Med; 2024 May; 28(10):e18445. PubMed ID: 38801403
[TBL] [Abstract][Full Text] [Related]
48. IgG4-related autoimmune prostatitis: two cases with or without autoimmune pancreatitis.
Nishimori I; Kohsaki T; Onishi S; Shuin T; Kohsaki S; Ogawa Y; Matsumoto M; Hiroi M; Hamano H; Kawa S
Intern Med; 2007; 46(24):1983-9. PubMed ID: 18084121
[TBL] [Abstract][Full Text] [Related]
49. Intraepithelial lymphocytes in relation to NIH category IV prostatitis in autopsy prostate.
Dikov D; Bachurska S; Staikov D; Sarafian V
Prostate; 2015 Jul; 75(10):1074-84. PubMed ID: 25917232
[TBL] [Abstract][Full Text] [Related]
50. Proteinase-activated receptor-1 and immunomodulatory effects of a PAR1-activating peptide in a mouse model of prostatitis.
Stanton MM; Nelson LK; Benediktsson H; Hollenberg MD; Buret AG; Ceri H
Mediators Inflamm; 2013; 2013():748395. PubMed ID: 24459330
[TBL] [Abstract][Full Text] [Related]
51. The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.
Said MM; Bosland MC
Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):197-205. PubMed ID: 27909742
[TBL] [Abstract][Full Text] [Related]
52. Immunoglobulin G4-related prostatitis: a case-control study focusing on clinical and pathologic characteristics.
Buijs J; Maillette de Buy Wenniger L; van Leenders G; Verheij J; van Onna I; Hansen B; van Heerde M; Krak N; Beuers U; Bruno M; van Buuren H
Urology; 2014 Mar; 83(3):521-6. PubMed ID: 24581512
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical demonstration of Chlamydial antigens in association with prostatitis.
Shurbaji MS; Gupta PK; Myers J
Mod Pathol; 1988 Sep; 1(5):348-51. PubMed ID: 2467288
[TBL] [Abstract][Full Text] [Related]
54. Increased inflammatory factors activity in model rats with experimental autoimmune prostatitis.
Zhou XH; Li LD; Wu LM; Han L; Liu ZD; Yang JX; Lv YW; You CL; Zhou ZH
Arch Androl; 2007; 53(2):49-52. PubMed ID: 17453679
[TBL] [Abstract][Full Text] [Related]
55. Autoimmune prostatitis: state of the art.
Motrich RD; Maccioni M; Riera CM; Rivero VE
Scand J Immunol; 2007; 66(2-3):217-27. PubMed ID: 17635799
[TBL] [Abstract][Full Text] [Related]
56. Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis.
Elkahwaji JE; Zhong W; Hopkins WJ; Bushman W
Prostate; 2007 Jan; 67(1):14-21. PubMed ID: 17075821
[TBL] [Abstract][Full Text] [Related]
57. [Effect of danpu capsule on inflammatory factors in rat model of autoimmune prostatitis].
Li M; Zhang YQ; Wang Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Nov; 28(11):1018-21. PubMed ID: 19213347
[TBL] [Abstract][Full Text] [Related]
58. Effect of a phytotherapeutic agent, Eviprostat®, on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitis.
Sugimoto M; Oka M; Tsunemori H; Yamashita M; Kakehi Y
Prostate; 2011 Mar; 71(4):438-44. PubMed ID: 21254154
[TBL] [Abstract][Full Text] [Related]
59. Nonbacterial prostatitis caused by partial urethral obstruction in the rat.
Takechi S; Yokoyama M; Tanji N; Nishio S; Araki N
Urol Res; 1999 Oct; 27(5):346-50. PubMed ID: 10550522
[TBL] [Abstract][Full Text] [Related]
60. The phytotherapeutic agent, eviprostat, suppresses stromal proliferation and inflammation even after establishment of nonbacterial prostatitis in the rat prostate.
Shibuya S; Xia Z; Sugimoto M; Ueda N; Haba R; Kakehi Y
Urology; 2014 Mar; 83(3):528-34. PubMed ID: 24581515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
